SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17381375
Source:
http://linkedlifedata.com/resource/pubmed/id/17381375
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0012652
,
umls-concept:C0035525
,
umls-concept:C0332120
,
umls-concept:C0332281
,
umls-concept:C1175175
,
umls-concept:C1705413
pubmed:issue
4
pubmed:dateCreated
2007-3-26
pubmed:abstractText
To distinguish adverse events related to ribavirin therapy from those attributable to severe acute respiratory syndrome (SARS), and to determine the rate of potential ribavirin-related adverse events.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8111305
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenal Cortex Hormones
,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0277-0008
pubmed:author
pubmed-author:Canadian SARS Research Network
,
pubmed-author:DresserLindaL
,
pubmed-author:LouieMarieM
,
pubmed-author:MazzulliTonyT
,
pubmed-author:McGeerAllisonA
,
pubmed-author:MullerMatthew PMP
,
pubmed-author:RaboudJanetJ
,
pubmed-author:RayD CDC
,
pubmed-author:ReaElizabethE
,
pubmed-author:RichardsonSusan ESE
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
494-503
pubmed:meshHeading
pubmed-meshheading:17381375-Adrenal Cortex Hormones
,
pubmed-meshheading:17381375-Adult
,
pubmed-meshheading:17381375-Adverse Drug Reaction Reporting Systems
,
pubmed-meshheading:17381375-Anemia
,
pubmed-meshheading:17381375-Antiviral Agents
,
pubmed-meshheading:17381375-Bradycardia
,
pubmed-meshheading:17381375-Canada
,
pubmed-meshheading:17381375-Cohort Studies
,
pubmed-meshheading:17381375-Disease Outbreaks
,
pubmed-meshheading:17381375-Dose-Response Relationship, Drug
,
pubmed-meshheading:17381375-Female
,
pubmed-meshheading:17381375-Humans
,
pubmed-meshheading:17381375-Injections, Intravenous
,
pubmed-meshheading:17381375-Magnesium Deficiency
,
pubmed-meshheading:17381375-Male
,
pubmed-meshheading:17381375-Medical Records Systems, Computerized
,
pubmed-meshheading:17381375-Middle Aged
,
pubmed-meshheading:17381375-Retrospective Studies
,
pubmed-meshheading:17381375-Ribavirin
,
pubmed-meshheading:17381375-Severe Acute Respiratory Syndrome
,
pubmed-meshheading:17381375-Tetany
,
pubmed-meshheading:17381375-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.
pubmed:affiliation
Department of Microbiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. mmuller@mtsinai.on.ca
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't